Mutual of America Capital Management LLC Increases Stake in OrthoPediatrics Corp. (NASDAQ:KIDS)

Mutual of America Capital Management LLC grew its position in shares of OrthoPediatrics Corp. (NASDAQ:KIDS) by 57.1% in the fourth quarter, Holdings Channel reports. The institutional investor owned 169,021 shares of the company’s stock after buying an additional 61,412 shares during the period. Mutual of America Capital Management LLC’s holdings in OrthoPediatrics were worth $3,918,000 as of its most recent filing with the SEC.

A number of other large investors also recently bought and sold shares of KIDS. Wellington Management Group LLP raised its position in OrthoPediatrics by 16.2% during the 3rd quarter. Wellington Management Group LLP now owns 883,221 shares of the company’s stock worth $23,944,000 after buying an additional 122,846 shares during the last quarter. Portolan Capital Management LLC increased its holdings in shares of OrthoPediatrics by 66.2% in the 3rd quarter. Portolan Capital Management LLC now owns 308,099 shares of the company’s stock valued at $8,353,000 after purchasing an additional 122,770 shares in the last quarter. Polar Asset Management Partners Inc. purchased a new position in shares of OrthoPediatrics in the 3rd quarter valued at about $2,288,000. Barclays PLC increased its holdings in shares of OrthoPediatrics by 319.3% in the 3rd quarter. Barclays PLC now owns 25,298 shares of the company’s stock valued at $686,000 after purchasing an additional 19,264 shares in the last quarter. Finally, Centiva Capital LP purchased a new position in shares of OrthoPediatrics in the 3rd quarter valued at about $319,000. Hedge funds and other institutional investors own 69.05% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the stock. Needham & Company LLC reiterated a “buy” rating and issued a $42.00 price target on shares of OrthoPediatrics in a report on Wednesday. Stifel Nicolaus cut their price target on shares of OrthoPediatrics from $40.00 to $32.00 and set a “buy” rating for the company in a report on Wednesday. Finally, Truist Financial cut their price target on shares of OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating for the company in a report on Wednesday, December 18th.

OrthoPediatrics Price Performance

Shares of NASDAQ KIDS opened at $25.61 on Thursday. The stock has a market cap of $620.17 million, a price-to-earnings ratio of -20.82 and a beta of 1.14. OrthoPediatrics Corp. has a 52 week low of $21.02 and a 52 week high of $35.99. The company’s 50-day moving average price is $24.39 and its 200 day moving average price is $25.94. The company has a current ratio of 7.17, a quick ratio of 3.68 and a debt-to-equity ratio of 0.19.

OrthoPediatrics (NASDAQ:KIDS) last issued its quarterly earnings data on Tuesday, March 4th. The company reported ($0.29) EPS for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.04. The firm had revenue of $52.67 million for the quarter, compared to analysts’ expectations of $51.16 million. OrthoPediatrics had a negative net margin of 15.00% and a negative return on equity of 5.78%. During the same period in the prior year, the company earned ($0.23) EPS. As a group, research analysts forecast that OrthoPediatrics Corp. will post -0.93 earnings per share for the current fiscal year.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.